Yee K, Bishop T R, Mather C, Zon L I
Division of Hematology, Children's Hospital of Boston, Harvard Medical School, MA 02115.
Blood. 1993 Aug 15;82(4):1335-43.
Activation of distinct receptor tyrosine kinases (RTK), such as the products of the c-fms and c-kit proto-oncogenes, profoundly affects hematopoietic development. We have isolated a novel RTK cDNA, called met-related kinase (MRK), which is expressed on early erythroid progenitors. MRK is also expressed in many hematopoietic cell lines, and is not lineage restricted. Several regions within the catalytic domain of MRK have amino acid similarity to the c-met proto-oncogene and v-sea oncogene. Specific polyclonal anti-MRK antisera detects an 84-Kd polypeptide in COS cells transfected with an expression vector containing the MRK cDNA. Further studies of this novel RTK will provide potential insight into its role during hematopoiesis.
不同受体酪氨酸激酶(RTK)的激活,如c-fms和c-kit原癌基因的产物,会深刻影响造血发育。我们分离出了一种新的RTK cDNA,称为met相关激酶(MRK),它在早期红系祖细胞上表达。MRK也在许多造血细胞系中表达,且不受谱系限制。MRK催化结构域内的几个区域与c-met原癌基因和v-sea癌基因具有氨基酸相似性。特异性多克隆抗MRK抗血清在转染了含有MRK cDNA的表达载体的COS细胞中检测到一条84-Kd的多肽。对这种新型RTK的进一步研究将为其在造血过程中的作用提供潜在的见解。